Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Assets Average (2016 - 2022)

Historic Assets Average for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Q3 2022 value amounting to $151.8 million.

  • Avadel Pharmaceuticals' Assets Average fell 4444.72% to $151.8 million in Q3 2022 from the same period last year, while for Sep 2022 it was $151.8 million, marking a year-over-year decrease of 4444.72%. This contributed to the annual value of $279.5 million for FY2021, which is 2069.41% up from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Assets Average stood at $151.8 million for Q3 2022, which was down 4444.72% from $189.5 million recorded in Q2 2022.
  • Over the past 5 years, Avadel Pharmaceuticals' Assets Average peaked at $334.5 million during Q3 2020, and registered a low of $151.8 million during Q3 2022.
  • For the 5-year period, Avadel Pharmaceuticals' Assets Average averaged around $242.5 million, with its median value being $255.7 million (2021).
  • In the last 5 years, Avadel Pharmaceuticals' Assets Average plummeted by 4756.1% in 2019 and then skyrocketed by 10803.55% in 2020.
  • Quarter analysis of 5 years shows Avadel Pharmaceuticals' Assets Average stood at $229.7 million in 2018, then tumbled by 33.09% to $153.7 million in 2019, then skyrocketed by 108.01% to $319.6 million in 2020, then fell by 20.01% to $255.7 million in 2021, then tumbled by 40.61% to $151.8 million in 2022.
  • Its last three reported values are $151.8 million in Q3 2022, $189.5 million for Q2 2022, and $234.2 million during Q1 2022.